In vitro studies have revealed that introducing exogenous ghrelin can lead to a reduction in ubiquitin–proteasome activity and an enhancement of autophagy, thereby promoting apoptosis in CRC cells [35]. This evidence concerns the gene GHRL and colorectal carcinoma.